NASDAQ:XENE - Nasdaq - CA98420N1050 - Common Stock - Currency: USD
TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 9.43M | 18.44M | 32.17M | |||
Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
Operating Expenses | 237.52M | 214.05M | 138.58M | 97.43M | 63.47M | |||
Research and Development | 177.91M | 167.51M | 105.77M | 75.46M | 50.52M | |||
Selling, General, and Administrative Expenses | 59.61M | 46.54M | 32.81M | 21.97M | 12.94M | |||
Operating Income | -237.52M | -214.05M | -129.14M | -78.99M | -31.30M | |||
Interest Income/Expense | 38.19M | 31.37M | 3.89M | 110.00K | 3.20M | |||
Non Recurring Items | N/A | N/A | 0.00 | 0.00 | -990.00K | |||
Income Before Taxes | -199.34M | -182.69M | -125.26M | -78.89M | -29.09M | |||
Income Tax | -286.00K | -292.00K | 120.00K | -10.00K | -260.00K | |||
Net Income | -199.06M | -182.39M | -124.94M | -77.09M | -28.01M | |||
EBITDA | -233.68M | -210.51M | -127.52M | -78.08M | -30.66M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -2.73 | -2.73 | -2.06 | -1.77 | -0.81 | |||
Non GAAP EPS | -2.74 | -2.72 | -2.04 | -1.77 | -0.81 | |||
Statistics | ||||||||
Profit Margin | N/A | N/A | -1324.92% | -418.06% | -87.07% | |||
Operating Profit Margin | N/A | N/A | -1369.46% | -428.36% | -97.30% |
All data in USD